In vitro, functional assays indicated that the depletion of HULC suppressed osteosarcoma cell proliferation, migration and invasion but induced apoptosis (Fig. 2), demonstrating the potential of HULC as a therapeutic target for osteosarcoma intervention. The gene discussed is HULC; the disease is osteosarcoma.